Contents of four active components in different commercial crude drugs and preparations of danshen (Salvia miltiorrhiza)

Acta Pharmacologica Sinica

Volumn 23, Issue 12, 2002, Pages 1163-1168

  Zhang, Hui ^a   Yu, Chen ^a   Jia, Jing Ying ^a   Leung, Susan Wai Sum ^b   Siow, Yaw Loong ^b   Man, Ricky Ying Keung ^b,d   Zhu, Da Yuan ^c  

^a Shanghai Xu Hui Dist Ctrl Hospital   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

High pressure liquid chromatography; Magnesium tanshinoate B (MTB); Salvia miltiorrhiza

Indexed keywords

3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; CHINESE DRUG; CRYPTOTANSHINONE; ISOTANSHINONE IIA; MAGNESIUM TANSHINOATE B; PLANT EXTRACT; SALVIA MILTIORRHIZA EXTRACT; UNCLASSIFIED DRUG;

CHINESE MEDICINE; CONFERENCE PAPER; DRUG FORMULATION; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEDICINAL PLANT; NONHUMAN; PLANT ROOT; SALVIA MILTIORRHIZA; TRADITIONAL MEDICINE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUGS, CHINESE HERBAL; INJECTIONS; LACTATES; MAGNESIUM; PHENANTHRENES; PHENANTHROLINES; PLANTS, MEDICINAL; SALVIA MILTIORRHIZA; TABLETS;

EID: 0036902502     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. The State Pharmacopoeia Commission of China. Pharmacopoeia of the People's Republic of China; v 1. Beijing: Chemical Industry Press; 2000.
2. Luo HW. Chemical basis for therapeutic effects of DanShen. Progress of Pharmacolchemistry; v 1. Beijing: China Medical Science Technology Press; 2000. p 201-215.
3. Fung KP, Wu J, Zeng LH, Wong HN, Lee CM, Hon PM, et al. Lithospermic acid B as an antioxidant-based protector of cultured ventricular myocytes and aortic endothelial cells of rabbits. Life Sci 1993; 53: 189-93.
4. Shigematsu T, Tajima S, Nishikawa T, Murad S, Pinnell SR, Nishioka I. Inhibition of collagen hydroxylation by lithospermic acid magnesium salt, a novel compound isolated from Salviae miltiorrhizae Radix. Biochim Biophys Acta 1994; 1200: 79-83.
5. Yokozawa T, Chung HY, Dong E, Oura H. Confirmation that magnesium lithospermate B has a hydroxyl radical-scavenging action. Exp Toxicol Pathol 1995; 47: 341-4.
6. Kasimu R, Tanaka K, Tezuka Y, Gong ZN, Li JX, Basnet P, et al. Comparative study of seventeen Salvia plants: Aldose reductase inhibitory activity of water and MeOH extracts and liquid chromatography-mass spectrometry (LC-MS) analysis of water extracts. Chem Pharm Bull (Tokyo) 1998; 46: 500-4.
7. Chen CP, Yokozawa T, Chung HY. Inhibitory effect of caffeic acid analogues isolated from Salviae miltiorrhizae Radix against 1,1-diphenyl-2-picrylhydrazyl radical. Exp Toxicol Pathol 1999; 51: 59-63.
8. Wu XJ, Wang YP, Wang W, Sun WK, Xu YM, Xuan LJ. Free radical scavenging and inhibition of lipid peroxidation by magnesium lithospermate B. Acta Pharmacol Sin 2000; 21: 855-8.
9. O K, Lynn EG, Vazhappilly R, Au-Yeung KK, Zhu DY, Siow YL. Magnesium tanshinoate B (MTB) inhibits low density lipoprotein oxidation. Life Sci 2001; 68: 903-12.
10. Yokozawa T, Chung HY, Lee TW, Oura H, Tanaka T, Nonaka G, et al. Contribution of prostaglandins to the renal responses to magnesium lithospermate B isolated from Salviae miltiorrhizae radix. Chem Pharm Bull (Tokyo) 1989; 37: 1568-71.
11. Yokozawa T, Lee TW, Chung HY, Oura H, Nonaka G, Nishioka I. Renal responses to magnesium lithospermate B. J Pharm Pharmacol 1990; 42: 712-5.
12. Yokozawa T, Lee TW, Oura H, Nonaka G, Nishioka I. Effect of magnesium lithospermate B in rats with sodium-induced hypertension and renal failure. Nephron 1992; 60: 460-5.
13. Fung KP, Zeng LH, Wu J, Wong HN, Lee CM, Hon PM, et al. Demonstration of the myocardial salvage effect of lithospermic acid B isolated from the aqueous extract of Salvia miltiorrhiza. Life Sci 1993; 52: 239-44.
14. Kamata K, Noguchi M, Nagai M. Hypotensive effects of lithospermic acid B isolated from the extract of Salviae miltiorrhizae Radix in the rat. Gen Pharmacol 1994; 25: 69-73.
15. Hase K, Kasimu R, Basnet P, Kadota S, Namba T. Preventive effect of lithospermate B from Salvia miltiorhiza on experimental hepatitis induced by carbon tetrachloride or D-galactosamine/lipopolysaccharide. Planta Med 1997; 63: 22-6.
16. Yokozawa T, Dong E, Oura H, Kashiwagi H, Nonaka G, Nishioka I. Magnesium lithospermate B suppresses the increase of active oxygen in rats after subtotal nephrectomy. Nephron 1997; 75: 88-93.
17. Yokozawa T, Oura H, Nishioka I. Confirmation that magnesium lithospermate B ameliorates paraquat-induced injury in cultured renal epithelial cells. Nephron 1998; 79: 373-4.
18. O K, Cheung F, Sung FL, Zhu DY, Siow YL. Effect of magnesium tanshinoate B on the production of nitric oxide in endothelial cells. Mol Cell Biochem 2000; 207: 35-9.
19. Wang W, Wang YP, Sun WK, Xu YM, Xuan LJ. Effects of magnesium lithospermate B on aggregation and 5-HT release in rabbit washed platelets. Acta Pharmacol Sin 2000; 21: 859-63.
20. Chen YH, Du GH, Zhang JT. Salvianolic acid B protects brain against injuries caused by ischemia-reperfusion in rats. Acta Pharmacol Sin 2000; 21: 463-6.
21. Luo WB, Wang YP. Magnesium lithospermate B inhibits hypoxia-induced calcium influx and nitric oxide release in endothelial cells. Acta Pharmacol Sin 2001; 22: 1135-42.
22. Au-Yeung KK, Zhu DY, O K, Siow YL. Inhibition of stress-activated protein kinase in the ischemic/reperfused heart: Role of magnesium tanshinoate B in preventing apoptosis. Biochem Pharmacol 2001; 62: 483-93.